|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
146,000,000 |
Market
Cap: |
15.86(B) |
Last
Volume: |
1,605,892 |
Avg
Vol: |
1,353,529 |
52
Week Range: |
$92.79 - $209.935 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Electronics |
Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 11.4 |
Insider 3/6 Months : 12 |
|
Guru Rank Number : 691 |
Guru Rank Value : 2.3 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co. provides whole-genome sequencing, genotyping, noninvasive prenatal testing (NIPT), and product support services. Using Co.'s services, customers can perform whole-genome sequencing projects and microarray projects (including large-scale genotyping studies and whole-genome association studies). Co. provides NIPT services through its partner laboratories that direct samples to Co. on a test send-out basis in its Clinical Laboratory Improvements Amendments-certified, College of Pathologists-accredited laboratory. Co. also provides support services to customers who have purchased its products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
7,330 |
7,330 |
7,330 |
Total Buy Value |
$0 |
$991,672 |
$991,672 |
$991,672 |
Total People Bought |
0 |
1 |
1 |
1 |
Total Buy Transactions |
0 |
1 |
1 |
1 |
Total Shares Sold |
0 |
0 |
1,815 |
22,740 |
Total Sell Value |
$0 |
$0 |
$314,105 |
$4,648,975 |
Total People Sold |
0 |
0 |
2 |
3 |
Total Sell Transactions |
0 |
0 |
4 |
17 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Epstein Robert S |
Director |
|
2019-05-23 |
4 |
D |
$308.97 |
$181,983 |
D/D |
(589) |
2,667 |
|
- |
|
Guthart Gary S |
Director |
|
2019-05-23 |
4 |
D |
$308.97 |
$181,983 |
D/D |
(589) |
4,454 |
|
- |
|
Dorsa Caroline |
Director |
|
2019-05-23 |
4 |
D |
$308.97 |
$181,983 |
D/D |
(589) |
7,263 |
|
- |
|
Flatley Jay T |
Director |
|
2019-05-22 |
4 |
AS |
$304.44 |
$1,004,652 |
D/D |
(3,300) |
282,516 |
|
- |
|
Ronaghi Mostafa |
SVP & CTO |
|
2019-05-15 |
4 |
AS |
$301.82 |
$3,054,876 |
D/D |
(10,000) |
77,414 |
|
- |
|
Ronaghi Mostafa |
SVP & CTO |
|
2019-05-15 |
4 |
OE |
$69.34 |
$693,400 |
D/D |
10,000 |
87,414 |
|
- |
|
Ostadan Omead |
SVP Mktg, Prod & Strat Plan |
|
2019-05-10 |
4 |
AS |
$315.32 |
$397,303 |
D/D |
(1,260) |
13,205 |
|
- |
|
Flatley Jay T |
Director |
|
2019-05-08 |
4 |
AS |
$318.59 |
$1,051,347 |
D/D |
(3,300) |
285,816 |
|
- |
|
Epstein Robert S |
Director |
|
2019-05-01 |
4 |
AS |
$309.51 |
$1,552,178 |
D/D |
(5,000) |
3,256 |
|
- |
|
Epstein Robert S |
Director |
|
2019-05-01 |
4 |
OE |
$51.17 |
$255,850 |
D/D |
5,000 |
8,256 |
|
- |
|
Dadswell Charles |
SVP & General Counsel |
|
2019-05-01 |
4 |
AS |
$311.77 |
$38,659 |
D/D |
(124) |
8,086 |
|
- |
|
Desouza Francis A |
President and CEO |
|
2019-05-01 |
4 |
AS |
$309.42 |
$930,029 |
D/D |
(3,000) |
70,936 |
|
- |
|
Flatley Jay T |
Director |
|
2019-04-10 |
4 |
AS |
$317.01 |
$1,046,133 |
D/D |
(3,300) |
331,668 |
|
- |
|
Desouza Francis A |
President and CEO |
|
2019-04-01 |
4 |
AS |
$314.86 |
$947,788 |
D/D |
(3,000) |
73,746 |
|
- |
|
Dadswell Charles |
SVP & General Counsel |
|
2019-04-01 |
4 |
AS |
$314.45 |
$38,992 |
D/D |
(124) |
8,210 |
|
- |
|
Epstein Robert S |
Director |
|
2019-04-01 |
4 |
AS |
$314.45 |
$314,450 |
D/D |
(1,000) |
3,256 |
|
- |
|
Epstein Robert S |
Director |
|
2019-04-01 |
4 |
OE |
$51.17 |
$51,170 |
D/D |
1,000 |
4,256 |
|
- |
|
Flatley Jay T |
Director |
|
2019-03-27 |
4 |
AS |
$306.93 |
$1,012,869 |
D/D |
(3,300) |
334,968 |
|
- |
|
Flatley Jay T |
Director |
|
2019-03-13 |
4 |
AS |
$306.50 |
$1,011,450 |
D/D |
(3,300) |
338,268 |
|
- |
|
Epstein Robert S |
Director |
|
2019-03-01 |
4 |
AS |
$313.93 |
$313,930 |
D/D |
(1,000) |
3,256 |
|
- |
|
Epstein Robert S |
Director |
|
2019-03-01 |
4 |
OE |
$51.17 |
$51,170 |
D/D |
1,000 |
4,256 |
|
- |
|
Desouza Francis A |
President and CEO |
|
2019-03-01 |
4 |
AS |
$314.17 |
$949,518 |
D/D |
(3,000) |
76,746 |
|
- |
|
Dadswell Charles |
SVP & General Counsel |
|
2019-03-01 |
4 |
AS |
$313.93 |
$382,995 |
D/D |
(1,220) |
8,334 |
|
- |
|
Flatley Jay T |
Director |
|
2019-02-27 |
4 |
AS |
$300.00 |
$990,000 |
D/D |
(3,300) |
341,568 |
|
- |
|
Hoyt Aimee L |
SVP, Chief People Officer |
|
2019-02-26 |
4 |
AS |
$304.63 |
$90,780 |
D/D |
(298) |
2,297 |
|
- |
|
1655 Records found
|
|
Page 21 of 67 |
|
|